CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory focused on package and container testing for the pharmaceutical, biotechnology, and medical device industries, announced on Tuesday the appointment of Jennifer Roark as director of Scientific Affairs.
In this position Roark will play a key management role in the continued growth and expansion of the CS Analytical service offering, will assist in the leadership development of key staff members, and will represent CS Analytical amongst industry groups including ASTM, USP, and PDA.
"With more than 30 years of experience in analytical chemistry and quality control testing within a cGMP environment specifically in the areas of extractables and leachables and container closure integrity testing for both pharmaceutical packaging systems and drug delivery devices, Jen brings a level of knowledge and understanding to the CS Analytical Team that can help and benefit our clients as they work to develop and qualify their package systems," said CS Analytical chief executive officer Brian Mulhall.
Roark has experience in managing groups that perform quality control testing in a cGMP environment, has been involved with numerous methods development and validation programmes, and has co-published a series of articles on analytical method validation.
Lupin's Dapagliflozin Tablets launched in US market
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules
Lupin's Dapagliflozin Tablets receive US regulatory approval
Dexcel Pharma's Nintedanib Capsules approved for US launch
FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer
Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency